RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms
Public ClinicalTrials.gov record NCT05965752. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
RECOVER-NEURO: A Platform Protocol for Evaluation of Interventions for Cognitive Dysfunction in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This platform protocol is designed to be flexible so that it is suitable for a wide range of settings within health care systems, for remote settings, and in community settings where it can be integrated into COVID-19 programs and subsequent treatment plans. This protocol is a prospective, multi-center, multi-arm, randomized, controlled platform trial evaluating potential interventions for PASC-mediated cognitive dysfunction. The hypothesis is that PASC associated dysfunction in cognitive domains, such as executive function and attention, may be improved by interventions that selectively focus on enhancing those domains.
Study identification
- NCT ID
- NCT05965752
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 328 participants
Conditions and interventions
Conditions
Interventions
- BrainHQ/Active Comparator Activity Other
- BrainHQ Other
- PASC CoRE Other
- tDCS-active Device
- tDCS-sham Device
Other · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 1, 2023 (Actual)
- Primary completion
- Jun 10, 2024 (Actual)
- Completion
- Jun 10, 2024 (Actual)
- Last update posted
- Jul 18, 2025
2023 – 2024
United States locations
- U.S. sites
- 24
- U.S. states
- 16
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner University Medical Center Phoenix | Phoenix | Arizona | 85006 | — |
| Banner University Medical Center- Tucson | Tucson | Arizona | 85719 | — |
| Ronald Reagan UCLA Medical Center | Los Angeles | California | 90095 | — |
| Stanford University | Stanford | California | 94305 | — |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Torrance | California | 90509 | — |
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | — |
| University of Florida College of Medicine Jacksonville | Jacksonville | Florida | 32256 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| OSF Healthcare | Peoria | Illinois | 61801 | — |
| North Shore University Health System/Evanston Hospital | Skokie | Illinois | 60076 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Jadestone Clinical Research | Silver Spring | Maryland | 20904 | — |
| Boston Medical Center | Boston | Massachusetts | 02118 | — |
| Beth Israel Daeconess Medical Center | Boston | Massachusetts | 02215 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| NYU Langone Health/Brooklyn Hospital | Brooklyn | New York | 11220 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| Case Western Reserve University | Cleveland | Ohio | 44106 | — |
| University of Texas Health Science Center at Houston | Houston | Texas | 77030 | — |
| University of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229 | — |
| University of Utah Hospitals and Clinics | Salt Lake City | Utah | 84132 | — |
| University of Vermont | Burlington | Vermont | 05401 | — |
| University of Washington | Seattle | Washington | 98109 | — |
| West Virginia Clinical and Translational Science Institute | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05965752, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 18, 2025 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05965752 live on ClinicalTrials.gov.